+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Estimation of the incidence of a rare genetic disease through a two-tier mutation survey

American Journal of Human Genetics 52(6): 1129-1138

Estimation of the incidence of a rare genetic disease through a two-tier mutation survey

Recent attempts to detect mutations involving single base changes or small deletions that are specific to genetic diseases provide an opportunity to develop a two-tier mutation-screening program through which incidence of rate genetic disorders and gene carriers may be precisely estimated. A two-tier survey consists of mutation screening in a sample of patients with specific genetic disorders and in a second sample of newborns from the same population in which mutation frequency is evaluated. We provide the statistical basis for evaluating the incidence of affected and gene carriers in such two-tier mutation-screening surveys, from which the precision of the estimates is derived. Sample-size requirements of such two-tier mutation-screening surveys are evaluated. Considering examples of cystic fibrosis (CF) and medium-chain acyl-CoA dehydrogenase deficiency (MCAD), the two most frequent autosomal recessive disease in Caucasian populations and the two most frequent mutations (DELTA-F508 and G985) that occur on these disease allele-bearing chromosomes, we show that, with 50-100 patients and a 20-fold larger sample of newborns screened for these mutations, the incidence of such diseases and their gene carriers in a population may be quite reliably estimated. The theory developed here is also applicable to rare autosomal dominant diseases for which disease-specific mutations are found.

Accession: 002373463

PMID: 8503445

Related references

Chakraborty R., 1984: Genetic variation detected by rare alleles and estimation of relative electrophoretic mutation rates in man. American Journal of Physical Anthropology 63(2): 145

Anonymous, 1983: Estimation of genetic risks and increased incidence of genetic disease due to environmental mutagens. In the estimation of the genetic hazards of environmental mutagens there are major problems in extrapolating from experimental data to human situations. Methods of overcoming these problems have been proposed, and may be achieved in the future. At...

Ferreira, S.; Devadason, D.; Denvir, L.; Seale, A.; Gupte, G., 2015: GATA6 mutation: a rare genetic cause of hepatobiliary disease. Journal of Pediatric Gastroenterology and Nutrition: -

Trimble, B.K.; Smith, M.E., 1977: The incidence of genetic disease and the impact on man of an altered mutation rate. In order to adequately assess the genetic risks to man of an altered mutation rate, it is necessary to know the naturally occurring frequency of mutation-maintained genetic ill-health and the burden that such defects impose. The relevant data that...

Yan, S-Huo.; Lao, K-Gan.; Fu, K-Peng.; Gong, F-Fei.; Wen, X-Jun.; Zhou, W-Jun., 2016: Hemoglobin H disease with a rare α-thalassemia gene mutation (-- SEA /α *92A>G α): pedigree analysis and genetic diagnosis. To identify a rare α-thalassemia gene mutation in a family from south China and perform a pedigree analysis and genetic diagnosis of hemoglobin H (HbH) disease caused by this mutation. Peripheral blood samples were collected from the family membe...

Kaneko, H.; Horiike, S.; Nakai, H.; Ueda, Y.; Nakao, M.; Hirakawa, K.; Yokota, S.; Taniwaki, M.; Misawa, S.; Kashima, K., 1995: Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression. Neurofibromatosis 1 gene (NF1) is a tumor suppressor gene and the product of which down-regulates Nras protein by its GTPase activating protein-related domain (NF1-GRD). Although the incidence of NF1 mutation was reported to be rare in the chronic...

Munirajan, A.K.; Mohanprasad, B.K.; Shanmugam, G.; Tsuchida, N., 1998: Detection of a rare point mutation at codon 59 and relatively high incidence of H-ras mutation in Indian oral cancer. Analysis of H-, K- and N-ras genes for point mutations by PCR-SSCP and direct sequencing of 46 oral SCCs that were previously analyzed for p53 mutations revealed that 9 (20%) had point mutations in either the H-ras or the N-ras. A novel mutation a...

Ramos-Arroyo, M.A.; Moreno, S.; Valiente, A., 2005: Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing. Background: Prior to the discovery of the Huntington's disease (HD) mutation, the prevalence, incidence, and new mutation rates for this disease were based on the presence of progressive choreic movements and a positive family history. Object...

Remaschi, G.; Venturini, E.; Romano, F.; Perrone, A.; Montagnani, C.; Azzari, C.; Chiappini, E.; de Martino, M.; Galli, L., 2016: A rare cause of osteomyelitis with a rare genetic mutation: when Mycobacterium doesn't only mean tuberculosis. International Journal of Tuberculosis and Lung Disease 19(8): 999-1000

Matsunaga E., 1984: Perspectives in mutation epidemiology 1 incidence and prevalence of genetic disease excluding chromosomal aberrations in human populations. Biologisches Zentralblatt: 85-110